Association of Digoxin Application Approaches With Long-Term Clinical Outcomes in Rheumatic Heart Disease Patients With Heart Failure: A Retrospective Study

Objective: This retrospective, case–control study was executed to assess the effects of digoxin (DGX) use approaches [continuous use of DGX (cDGX) vs. intermittent use of DGX (iDGX)] on the long-term prognosis in rheumatic heart disease (RHD) patients with heart failure (HF).Methods: A total of 642...

Full description

Bibliographic Details
Main Authors: Cheng Liu, Yanxian Lai, Tianwang Guan, Qingchun Zeng, Jingxian Pei, Shenghui Zhang, Daihong Wu, Deping Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.711203/full
_version_ 1818736408646385664
author Cheng Liu
Cheng Liu
Yanxian Lai
Tianwang Guan
Qingchun Zeng
Jingxian Pei
Shenghui Zhang
Daihong Wu
Deping Wu
author_facet Cheng Liu
Cheng Liu
Yanxian Lai
Tianwang Guan
Qingchun Zeng
Jingxian Pei
Shenghui Zhang
Daihong Wu
Deping Wu
author_sort Cheng Liu
collection DOAJ
description Objective: This retrospective, case–control study was executed to assess the effects of digoxin (DGX) use approaches [continuous use of DGX (cDGX) vs. intermittent use of DGX (iDGX)] on the long-term prognosis in rheumatic heart disease (RHD) patients with heart failure (HF).Methods: A total of 642 RHD patients were enrolled to this study after propensity matching. The associations of DGX application approaches with the risks of all-cause mortality, cardiovascular death (CVD), HF re-hospitalization (1-, 3-, and 5-year), and new-onset atrial fibrillation (AF) were analyzed by multivariate Cox proportional hazards or binary logistic regression models, respectively.Results: cDGX was associated with increased risks of all-cause mortality (adjusted HR = 1.84, 95% CI: 1.27–2.65, P = 0.001) and CVD (adjusted HR = 2.23, 95% CI: 1.29–3.83, P = 0.004) in RHD patients with HF compared to iDGX. With exception of 1-year HF re-hospitalization risk, cDGX was associated with increased HF re-hospitalization risk of 3-year (adjusted OR = 1.53, 95% CI: 1.03–2.29, P = 0.037) and 5-year (adjusted OR = 1.61, 95% CI: 1.05–2.50, P = 0.031) as well as new-onset AF (adjusted OR = 2.06, 95% CI: 1.09–3.90, P = 0.027).Conclusion: cDGX was significantly associated with increased risks of all-cause mortality, CVD, medium-/long-term HF re-hospitalization, and new-onset AF in RHD patients with HF.
first_indexed 2024-12-18T00:36:41Z
format Article
id doaj.art-aa450ccccda9457d921c2968d471d7d7
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-12-18T00:36:41Z
publishDate 2021-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-aa450ccccda9457d921c2968d471d7d72022-12-21T21:26:59ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2021-09-01810.3389/fcvm.2021.711203711203Association of Digoxin Application Approaches With Long-Term Clinical Outcomes in Rheumatic Heart Disease Patients With Heart Failure: A Retrospective StudyCheng Liu0Cheng Liu1Yanxian Lai2Tianwang Guan3Qingchun Zeng4Jingxian Pei5Shenghui Zhang6Daihong Wu7Deping Wu8Department of Cardiology, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, ChinaDepartment of Cardiology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, ChinaDepartment of Cardiology, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, ChinaDepartment of Cardiology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, ChinaDepartment of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaDepartment of Cardiology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaDepartment of Cardiology, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, ChinaDepartment of Cardiology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, ChinaGuangzhou Center for Disease Control and Prevention, Guangzhou, ChinaObjective: This retrospective, case–control study was executed to assess the effects of digoxin (DGX) use approaches [continuous use of DGX (cDGX) vs. intermittent use of DGX (iDGX)] on the long-term prognosis in rheumatic heart disease (RHD) patients with heart failure (HF).Methods: A total of 642 RHD patients were enrolled to this study after propensity matching. The associations of DGX application approaches with the risks of all-cause mortality, cardiovascular death (CVD), HF re-hospitalization (1-, 3-, and 5-year), and new-onset atrial fibrillation (AF) were analyzed by multivariate Cox proportional hazards or binary logistic regression models, respectively.Results: cDGX was associated with increased risks of all-cause mortality (adjusted HR = 1.84, 95% CI: 1.27–2.65, P = 0.001) and CVD (adjusted HR = 2.23, 95% CI: 1.29–3.83, P = 0.004) in RHD patients with HF compared to iDGX. With exception of 1-year HF re-hospitalization risk, cDGX was associated with increased HF re-hospitalization risk of 3-year (adjusted OR = 1.53, 95% CI: 1.03–2.29, P = 0.037) and 5-year (adjusted OR = 1.61, 95% CI: 1.05–2.50, P = 0.031) as well as new-onset AF (adjusted OR = 2.06, 95% CI: 1.09–3.90, P = 0.027).Conclusion: cDGX was significantly associated with increased risks of all-cause mortality, CVD, medium-/long-term HF re-hospitalization, and new-onset AF in RHD patients with HF.https://www.frontiersin.org/articles/10.3389/fcvm.2021.711203/fullheart failure re-hospitalizationmortalityrheumatic heart diseaseapplication approachesdigoxinnew-onset atrial fibrillation
spellingShingle Cheng Liu
Cheng Liu
Yanxian Lai
Tianwang Guan
Qingchun Zeng
Jingxian Pei
Shenghui Zhang
Daihong Wu
Deping Wu
Association of Digoxin Application Approaches With Long-Term Clinical Outcomes in Rheumatic Heart Disease Patients With Heart Failure: A Retrospective Study
Frontiers in Cardiovascular Medicine
heart failure re-hospitalization
mortality
rheumatic heart disease
application approaches
digoxin
new-onset atrial fibrillation
title Association of Digoxin Application Approaches With Long-Term Clinical Outcomes in Rheumatic Heart Disease Patients With Heart Failure: A Retrospective Study
title_full Association of Digoxin Application Approaches With Long-Term Clinical Outcomes in Rheumatic Heart Disease Patients With Heart Failure: A Retrospective Study
title_fullStr Association of Digoxin Application Approaches With Long-Term Clinical Outcomes in Rheumatic Heart Disease Patients With Heart Failure: A Retrospective Study
title_full_unstemmed Association of Digoxin Application Approaches With Long-Term Clinical Outcomes in Rheumatic Heart Disease Patients With Heart Failure: A Retrospective Study
title_short Association of Digoxin Application Approaches With Long-Term Clinical Outcomes in Rheumatic Heart Disease Patients With Heart Failure: A Retrospective Study
title_sort association of digoxin application approaches with long term clinical outcomes in rheumatic heart disease patients with heart failure a retrospective study
topic heart failure re-hospitalization
mortality
rheumatic heart disease
application approaches
digoxin
new-onset atrial fibrillation
url https://www.frontiersin.org/articles/10.3389/fcvm.2021.711203/full
work_keys_str_mv AT chengliu associationofdigoxinapplicationapproacheswithlongtermclinicaloutcomesinrheumaticheartdiseasepatientswithheartfailurearetrospectivestudy
AT chengliu associationofdigoxinapplicationapproacheswithlongtermclinicaloutcomesinrheumaticheartdiseasepatientswithheartfailurearetrospectivestudy
AT yanxianlai associationofdigoxinapplicationapproacheswithlongtermclinicaloutcomesinrheumaticheartdiseasepatientswithheartfailurearetrospectivestudy
AT tianwangguan associationofdigoxinapplicationapproacheswithlongtermclinicaloutcomesinrheumaticheartdiseasepatientswithheartfailurearetrospectivestudy
AT qingchunzeng associationofdigoxinapplicationapproacheswithlongtermclinicaloutcomesinrheumaticheartdiseasepatientswithheartfailurearetrospectivestudy
AT jingxianpei associationofdigoxinapplicationapproacheswithlongtermclinicaloutcomesinrheumaticheartdiseasepatientswithheartfailurearetrospectivestudy
AT shenghuizhang associationofdigoxinapplicationapproacheswithlongtermclinicaloutcomesinrheumaticheartdiseasepatientswithheartfailurearetrospectivestudy
AT daihongwu associationofdigoxinapplicationapproacheswithlongtermclinicaloutcomesinrheumaticheartdiseasepatientswithheartfailurearetrospectivestudy
AT depingwu associationofdigoxinapplicationapproacheswithlongtermclinicaloutcomesinrheumaticheartdiseasepatientswithheartfailurearetrospectivestudy